Dr. Michael Cooney, Clinical Director
Pain News Network, RSDSA and other chronic pain organizations shared a New England Journal of Medicine research findings, “Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain,” authored by Thomas J. Smith, M.D., Eric J. Wang, M.D., and Charles L. Loprinzi, M.D.
I would like to offer my congratulations to my esteemed scrambler therapy partner, Dr. Thomas Smith, Johns Hopkins University School of Medicine, for this recognition as a result of his years of work supporting the value of non-invasive scrambler therapy.
“Scrambler therapy is the most exciting development I have seen in years — it’s effective, it’s noninvasive, it reduces opioid use substantially and it can be permanent,” notes Dr. Smith. “Although both scrambler therapy and TENS devices administer electrical stimulation through cutaneous adhesive electrodes, scrambler therapy is a distinct type of treatment, not a variation or subcategory of TENS.”
Some of the largest reviews and reports about the use of scrambler therapy to treat neuropathy indicate that 10 to 20 percent of patients had no analgesic (pain minimization) response to scrambler therapy, whereas approximately 80 to 90% had a favorable response.scrambler therapy can relieve treatment and medication resistant chronic nerve pain.
Dr. Michael Cooney is one of the world’s leading experts on the administration of Calmare scrambler therapy. One of fewer than 10 Calmare Certified providers in the US, he has successfully treated more than 1,500 children and adults with neuropathy. Call 201-933-4440 to schedule a personal phone or video consultation to discuss your chronic nerve pain condition.